Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1994 Apr;19(4):916-24.
doi: 10.1002/hep.1840190418.

Murine liver allograft transplantation: tolerance and donor cell chimerism

Affiliations

Murine liver allograft transplantation: tolerance and donor cell chimerism

S Qian et al. Hepatology. 1994 Apr.

Abstract

Nonarterialized orthotopic liver transplantation with no immunosuppression was performed in 13 mouse-strain combinations. Two strain combinations with major histocompatibility complex class I and class II and minor histocompatibility complex disparity had 20% and 33% survival of more than 100 days, but the other 11 combinations, including four that were fully allogeneic and all with only class I, class II or minor disparities, yielded 45% to 100% survival of more than 100 days. Long-living recipients permanently accepted donor-strain heterotopic hearts transplanted on the same day or donor-strain skin 3 mo after liver transplantation, in spite of detectable antidonor in vitro activity with mixed lymphocyte reaction and cell-mediated lymphocytotoxicity testing (split tolerance). In further donor-specific experiments, liver grafts were not rejected by presensitized major histocompatibility complex class I-disparate recipients and they protected donor-strain skin grafts from second set (or any) rejection. Less frequently, liver transplantation rescued rejecting skin grafts placed 1 wk earlier in major histocompatibility complex class I, class II and minor histocompatibility complex, class II or minor histocompatibility complex-disparate strain combinations. Donor-derived leukocyte migration to the central lymphoid organs occurred within 1 to 2 hr after liver transplantation in all animals examined, persisted in the surviving animals until they were killed (> 375 days), and was demonstrated with double-immunolabeling to be multilineage. The relation of these findings to so-called hepatic tolerogenicity and to tolerance in general is discussed.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Recipient spleen 7 mo after liver transplantation in the B10→C3H combination stained for donor-specific MHC class II [I_Ab] antigens. The majority of donor cells were found in the periarterial lymphatic sheath and the marginal zone (immunoperoxidase staining for I-Ab, counterstained with hematoxylin; original magnification × 40). Inset: (original magnification × 400 ) shows the individual cell staining (arrow) in greater detail.
Fig. 2
Fig. 2
Double immunofluorescent staining (DIF) controls for Lineage identity of donor cells in recipient tissues. (a) No staining was seen in negative controls (see “Materials and Methods”; original magnification × 400). (b) DIF staining of normal B10 lymph node (positive control) with anti-I-Ab (red, non–B cells) and anti-B-220 (green, B cells). Note red cells in the paracortex, which are only positive for I-Ab; the green cells in the cortex, which are only positive for B-220; and the yellow cells (class II-positive B cells), which are double positive for both I-Ab and B-220 (original magnification × 200). (c) DIF staining of the allografted liver with anti-I-Ab (red) and anti-B-220 (green) served as an additional control (original magnification × 400) Note red-only staining of biliary epithelium (donor I-Ab) and green-only staining of infiltrating recipients B-220–positive B cells. Lack of double-staining in bile ducts excludes possibility of nonspecific cross-reactivity of immunohistochemical reagents used. Arrow highlights lipofuscin autofluorescence.
Fig. 3
Fig. 3
Lineage identification of donor cells by double immunofluorescent staining (DIF) in recipients’ spleen 7 mo after OLT in B10→C3H combination. (a) DIF staining for donor I-Ab (red) and B-220 (B cells, green; original magnification × 100). A splenic arterial branch is located in the center. Single-positive donor non–B cells (large arrowhead, red-only) and double-positive donor B cells (small arrowhead, yellow) are located in the PALS. Inset: Yellow double-positive donor–B cell in greater detail (original magnification × 400). (b) Donor leukocytes of dendritic cell lineage could also be detected by DIF labeling (original magnification × 400). Red-only donor cell in the PALS is positive for donor I-Ab (large arrowhead), whereas green-only cells stain positive with mAb 2A1 (dendritic cell marker). The double-positive (bright yellow) cell is a donor dendritic cell (small arrowhead), which is stained for both donor class II and dendritic cell–associated antigen 2A1. (c) Donor T cells were also detected with DIF staining (original magnification × 400). Note red cells (large arrowhead), which are positive for donor MHC class I antigens (H-2Kb) alone; green cells, which are positive with mAb Thy 1.2 (T cells) alone; and donor T cell (bright yellow), which is positive for both donor class I and Thy 1.2 (small arrowhead). The Thy 1.2–stained cell could be a fibroblast, but confirmatory evidence of a donor subpopulation of T cells was obtained by double labeling with donor class I and CD4 or CD8.

References

    1. Starzl TE, Demetris AJ, Murase N, Ildstad S, Ricordi C, Trucco M. Cell migration, chimerism, and graft acceptance. Lancet. 1992;339:1579–1582. - PMC - PubMed
    1. Starzl TE, Demetris AJ, Trucco M, Ramos H, Zeevi A, Rudert WA, Kocoua M, et al. Systemic chimerism in human female recipients of male livers. Lancet. 1992;340:876–877. - PMC - PubMed
    1. Starzl TE, Demetris AJ, Trucco M, Ricordi C, Ildstad S, Terasaki P, Murase N, et al. Chimerism after liver transplantation for type IV glycogen storage disease and type I Gaucher’s disease. N Engl J Med. 1993;328:745–749. - PMC - PubMed
    1. Starzl TE, Demetris AJ, Trucco M, Zeevi A, Ramos H, Terasaki P, Rudert WA, et al. Chimerism and donor specific nonreactivity 27 to 29 years after kidney allotransplantation. Transplantation. 1993;55:1272–1277. - PMC - PubMed
    1. Starzl TE, Demetris AJ, Murase N, Thomson AW, Trucco M, Ricordi C. Cell chimerism permitted by immunosuppressive drugs is the basis of organ transplant acceptance and tolerance. Immunol Today. 1993;14:326–332. - PMC - PubMed

Publication types

MeSH terms

Substances